Auditors
Remuneration
Incentive program
Management
Board Of Directors
Committees
Nomination Committee
General Meeting
Articles Of Association
Governance Structure
Corporate Governance Reports

Management

The role of CEO is, subordinate to the Board of Directors and its main task is to carry out the daily management of Xbrane and the daily activities of the Company. The Board of Director’s rules of procedure and instructions for the CEO stipulate for which matters the Board of Directors is responsible to decide upon, and which decisions fall within the CEO’s area of responsibility. The CEO is also responsible for producing reports and necessary data for decision-making ahead of Board meetings and for presenting the material at Board meetings.

Xbrane has a management team consisting of six people, which in addition to the CEO is comprised of the COO/Head of Biosimilars, CFO/Head of IR, CTO, Head of Manufacturing & Supply Chain and Head of Clinical Affairs.

Management Team

CEO

Martin Åmark

Since 2015

Martin Åmark holds a M Sc. in industrial engineering and management from Linköping Institute of Technology and a MBA from INSEAD. He has 8 years of experience from Bain & Co as a management consultant. At Bain Martin worked mainly with M&A, strategy and organisation with Nordic clients across multiple industries, including life science and pharmaceuticals.

Shares: 7,412,166

COO & Head of Biosimilars

Siavash Bashiri

Since 2012

Siavash Bashiri holds a M Sc. in Molecular Biotechnology from Uppsala University. His latest position was with Agilent Technologies where he was the head of sales in EMEA for one of Agilent Technologies’ products within the Genomics department. He also has great knowledge of the commercialization of biotech start-ups from previous experiences.

Shares: 4,137,820

Interim CFO & Head of IR

Jane Benyamin

Since 2025

Jane Benyamin has a master’s degree in business administration from Södertörns Högskola. She has operated in the Life Science sector for 20 years, having held Senior Finance roles such as Chief Accounting Officer at Oncopeptides, CFO Bluefish Pharmaceuticals and Finance Manager at Pensa Pharma.

Shares: 0

CTO

Dr. David Vikström

Since 2014

David Vikström is the CTO of Xbrane Bioscience. He has a Ph.D. in expression and targeting of proteins in E. coli. He joined Xbrane in 2010 and successfully developed new technologies and strains for vaccine candidates. He is currently heading the development of Xbrane’s new expression systems to be able to take the expression in E. coli to new levels.

Shares: 464,953

Head of Manufacturing & Supply Chain

Anders Wallström

Since 2020

Anders Wallström holds a M. Sc. in Biotechnology from Royal Institute of Technology in Stockholm. He has more than 20 years of experience from process development, manufacturing and validation at SOBI and Biovitrum. Furthermore, he has significant experience from coordinating contract manufacturers for commercial products for both small molecule and biotech products.

Shares: 187,825

Head of Clinical Affairs

Dina Jurman

Since 2017

Dina Jurman holds a Master of Science degree in Biomedicine from Uppsala University and has extensive experience in clinical drug development of biological drugs, small molecules, and medical devices. With 20 years of experience in the pharmaceutical industry, she has successfully led projects from early development phases to product registration.

Shares: 420

NamePositionMember of the senior management sinceEmployed at the Company sinceHoldings in Xbrane - Shares
Martin ÅmarkCEO201520154,912,166
Siavash BashiriCOO & Head of Biosimilars201220124,137,820
Jane BenyaminInterim CFO & Head of IR202520250
David VikströmCTO20142014464,953
Anders WallströmHead of Manufacturing & Supply Chain20202019187,825
Dina JurmanHead of Clinical affairs20172017420